The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
Szkudelski, T. (2001) · Physiological Research · doi:10.33549/physiolres.930111 · Cited by 2,876
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416
Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 991
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
Self-citationStructure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with Inhibitor
Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A. K., Zhang, X. C., & Tang, J. (2000) · Science · doi:10.1126/science.290.5489.150 · Cited by 711
Ginkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565
de la Monte, S. M., & Wands, J. R. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7106 · Cited by 553
Ma, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536
Lannert, H., & Hoyer, S. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.5.1199 · Cited by 525
Self-citationRegulation of APP cleavage by α‐, β‐ and γ‐secretases
Nunan, J., & Small, D. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02076-7 · Cited by 512
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498
Li, N.-C., Lee, A., Whitmer, R. A., Kivipelto, M., Lawler, E., Kazis, L. E., & Wolozin, B. (2010) · BMJ · doi:10.1136/bmj.b5465 · Cited by 486
Baum, L., & Ng, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6403 · Cited by 483
Oxidative stress in Alzheimer disease: A possibility for prevention
Bonda, D. J., Wang, X., Perry, G., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 483
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Self-citationYan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469
Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease
Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
Hoyer, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.049 · Cited by 434
Self-citationForlenza, O. V., Diniz, B. S., Radanovic, M., Santos, F. S., Talib, L. L., & Gattaz, W. F. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.080044 · Cited by 402
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Sato, T., Hanyu, H., Hirao, K., Kanetaka, H., Sakurai, H., & Iwamoto, T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.009 · Cited by 387
Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A., Cotman, C., Cottrell, B., Montine, T. J., Thomas, R. G., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.85 · Cited by 377
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
Reitz, C. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/369808 · Cited by 376
Grünblatt, E., Salkovic‐Petrisic, M., Osmanovic, J., Riederer, P., & Hoyer, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04368.x · Cited by 374
Self-citationProgesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
Carroll, J. C., Rosario, E. R., Chang, L., Stanczyk, F. Z., Oddo, S., LaFerla, F. M., & Pike, C. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2718-07.2007 · Cited by 364
Javed, H., Khan, M. M., Ahmad, A., Vaibhav, K., Ahmad, M. E., Khan, A., Ashafaq, M., Islam, F., Siddiqui, M. S., Safhi, M. M., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.046 · Cited by 357
Jantzen, P. T., Connor, K. E., DiCarlo, G., Wenk, G. L., Wallace, J. L., Rojiani, A. M., Coppola, D., Morgan, D., & Gordon, M. N. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02246.2002 · Cited by 340
Causes of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336
Extended results of the Alzheimer's disease anti‐inflammatory prevention trial
Breitner, J. C., Baker, L. D., Montine, T. J., Meinert, C. L., Lyketsos, C. G., Ashe, K. H., Brandt, J., Craft, S., Evans, D. E., Green, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.014 · Cited by 328
Sharma, M., & Gupta, Y. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02083-0 · Cited by 326
de la Monte, S. M., Tong, M., Lester-Coll, N., Plater, Jr., & Wands, J. R. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10113 · Cited by 325
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Pedersen, W. A., McMillan, P. J., Kulstad, J. J., Leverenz, J. B., Craft, S., & Haynatzki, G. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.018 · Cited by 322
Hampel, H. J., Ewers, M., Bürger, K., Annas, P., Mörtberg, A., Bogstedt, A., Frölich, L., Schröder, J., Schönknecht, P., Riepe, M. W., et al. (2009) · PubMed · Cited by 305
Jaturapatporn, D., Isaac, M. G. E. K. N., McCleery, J., & Tabet, N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006378.pub2 · Cited by 299
Wang, J., Ho, L., Zhao, Z., Seror, I., Humala, N., Dickstein, D. L., Thiyagarajan, M., Percival, S. S., Talcott, S. T., & Maria Pasinetti, G. (2006) · The FASEB Journal · doi:10.1096/fj.06-6281com · Cited by 298
Hampel, H., Ewers, M., Bürger, K., Annas, P., Mörtberg, A., Bogstedt, A., Frölich, L., Schröder, J., Schönknecht, P., Riepe, M. W., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04606 · Cited by 295
Toledo, E. M., & Inestrosa, N. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.72 · Cited by 293
Bosco, D., Fava, A., Plastino, M., Montalcini, T., & Pujia, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01318.x · Cited by 283
Oddo, S., Vasilevko, V., Caccamo, A., Kitazawa, M., Cribbs, D. H., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608485200 · Cited by 283
Developing β‐secretase inhibitors for treatment of Alzheimer’s disease
Ghosh, A. K., Brindisi, M., & Tang, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07476.x · Cited by 272
Hoyer, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050067 · Cited by 265
Self-citationNicolakakis, N., Aboulkassim, T., Ongali, B., Lecrux, C., Fernandes, P., Rosa-Neto, P., Tong, X.-K., & Hamel, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3348-08.2008 · Cited by 262
Sharma, M., & Gupta, Y. K. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)01005-5 · Cited by 260
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex
Kornhuber, J., Bormann, J., Retz, W., Hübers, M., & Riederer, P. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90384-1 · Cited by 253
Self-citationVeerendra Kumar, M., & Gupta, Y. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03842.x · Cited by 249
Salkovic-Petrisic, M., & Hoyer, S. (2007) · Neuropsychiatric Disorders An Integrative Approach · doi:10.1007/978-3-211-73574-9_28 · Cited by 247
Self-citationHashimoto, M., Kazui, H., Matsumoto, K., Nakano, Y., Yasuda, M., & Mori, E. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.676 · Cited by 242
Escribano, L., Simón, A.-M., Gimeno, E., Cuadrado-Tejedor, M., López de Maturana, R., García-Osta, A., Ricobaraza, A., Pérez-Mediavilla, A., Del Río, J., & Frechilla, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.32 · Cited by 235
Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats.
Kadowaki, T., Kasuga, M., Akanuma, Y., Ezaki, O., & Takaku, F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89879-9 · Cited by 232
Ishrat, T., Hoda, M. N., Khan, M. B., Yousuf, S., Ahmad, M., Khan, M. M., Ahmad, A., & Islam, F. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.002 · Cited by 230
Stackman, R. W., Eckenstein, F., Frei, B., Kulhanek, D., Nowlin, J., & Quinn, J. F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00399-6 · Cited by 230
Therapeutic potential of resveratrol in Alzheimer's disease
Vingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., & Marambaud, P. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s6 · Cited by 224
Geldmacher, D. S., Fritsch, T., McClendon, M. J., & Landreth, G. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.229 · Cited by 221
Shepardson, N. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.203 · Cited by 221
Salkovic‐Petrisic, M., Tribl, F., Schmidt, M., Hoyer, S., & Riederer, P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03637.x · Cited by 221
Self-citationWang, Y.-J., Thomas, P., Zhong, J.-H., Bi, F.-F., Kosaraju, S., Pollard, A., Fenech, M., & Zhou, X.-F. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9000-x · Cited by 220
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
Correia, S. C., Santos, R. X., Perry, G., Zhu, X., Moreira, P. I., & Smith, M. A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.01.001 · Cited by 212
Montgomery, S. A., Thal, L. J., & Amrein, R. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00001 · Cited by 209
Ishrat, T., Parveen, K., Khan, M. M., Khuwaja, G., Khan, M. B., Yousuf, S., Ahmad, A., Shrivastav, P., & Islam, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.010 · Cited by 199
Harrington, C., Sawchak, S., Chiang, C., Davies, J., Donovan, C., M. Saunders, A., Irizarry, M., Jeter, B., Zvartau-Hind, M., H. van Dyck, C., et al. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391935 · Cited by 197
Deshmukh, R., Sharma, V., Mehan, S., Sharma, N., & Bedi, K. L. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.027 · Cited by 194
Ishrat, T., Khan, M. B., Hoda, M. N., Yousuf, S., Ahmad, M., Ansari, M. A., Ahmad, A. S., & Islam, F. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.009 · Cited by 189
Dragicevic, N., Copes, N., O’Neal-Moffitt, G., Jin, J., Buzzeo, R., Mamcarz, M., Tan, J., Cao, C., Olcese, J. M., Arendash, G. W., et al. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00864.x · Cited by 185
Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease
Minkeviciene, R., Banerjee, P., & Tanila, H. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071027 · Cited by 184
Shepardson, N. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.242 · Cited by 181
Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A., & Zhu, X. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9360-7 · Cited by 180
Mayer, G., Nitsch, R., & Hoyer, S. (1990) · Brain Research · doi:10.1016/0006-8993(90)91747-5 · Cited by 180
Self-citationPlaschke, K., & Hoyer, S. (1993) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(93)90021-5 · Cited by 178
Self-citationZahs, K. R., & Ashe, K. H. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.05.004 · Cited by 175
α-Lipoic acid as a new treatment option for Alzheimer’s disease — a 48 months follow-up analysis
Häger, K., Kenklies, M., McAfoose, J., Engel, J., & Münch, G. W. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_24 · Cited by 169
Gutzmann, H., & Hadler, D. (1998) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-7508-8_30 · Cited by 162
Tiwari, V., Kuhad, A., Bishnoi, M., & Chopra, K. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.05.009 · Cited by 161
Pathan, A. R., Viswanad, B., Sonkusare, S. K., & Ramarao, P. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.07.018 · Cited by 161
Tota, S., Awasthi, H., Kamat, P. K., Nath, C., & Hanif, K. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.017 · Cited by 160
Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
Danielyan, L., Klein, R., Hanson, L. R., Buadze, M., Schwab, M., Gleiter, C. H., & Frey, W. H. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0944 · Cited by 158
Saxena, G., Singh, S. P., Agrawal, R., & Nath, C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.009 · Cited by 157
Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease
Thal, L. J., Grundman, M., Berg, J., Ernstrom, K., Margolin, R., Pfeiffer, E., Weiner, M. F., Zamrini, E., & Thomas, R. G. (2003) · Neurology · doi:10.1212/01.wnl.0000096376.03678.c1 · Cited by 156
Šalković‐Petrišić, M., Barilar, J. O., Brückner, M. K., Hoyer, S., Arendt, T., & Riederer, P. F. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0651-4 · Cited by 155
Self-citationInsulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model
Agrawal, R., Tyagi, E., Shukla, R., & Nath, C. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.009 · Cited by 153
Takeda, S., Sato, N., Rakugi, H., & Morishita, R. (2011) · Molecular BioSystems · doi:10.1039/c0mb00302f · Cited by 150
Nitsch, R. M., & Hoyer, S. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90260-z · Cited by 149
Self-citationDong, Y., Kataoka, K., Tokutomi, Y., Nako, H., Nakamura, T., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Ogawa, H., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-182873 · Cited by 148
Chen, S., Liu, A., An, F.-M., Yao, W., & Gao, X. (2011) · AGE · doi:10.1007/s11357-011-9303-8 · Cited by 143
Sonkusare, S. K., Srinivasan, K. K., Kaul, C., & Ramarao, P. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.036 · Cited by 142
Santana, S., Recuero, M., Bullido, M. J., Valdivieso, F., & Aldudo, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.010 · Cited by 140
Shoham, S., Bejar, C., Kovalev, E., Schorer-Apelbaum, D., & Weinstock, M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.005 · Cited by 136
Peskind, E. R., Tsuang, D. W., Bonner, L. T., Pascualy, M., Riekse, R. G., Snowden, M. B., Thomas, R. G., & Raskind, M. A. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000155067.16313.5e · Cited by 134
Melnikova, T., Savonenko, A. V., Wang, Q., Liang, X., Hand, T. A., Wu, L., Kaufmann, W. E., Vehmas, A. K., & Andreasson, K. I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.001 · Cited by 134
Agrawal, R., Mishra, B., Tyagi, E., Nath, C., & Shukla, R. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.008 · Cited by 133
Šalković‐Petrišić, M., Barilar, J. O., Grünblatt, E., Riederer, P. F., & Hoyer, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1184 · Cited by 133
Self-citationVitamin E in Neurodegenerative Disorders: Alzheimer's Disease
Kontush, A., & Schekatolina, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.025 · Cited by 132
Saxena, G., Singh, S. P., Pal, R., Singh, S., Pratap, R., & Nath, C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.03.010 · Cited by 130
Levin-Allerhand, J. A., Lominska, C. E., Wang, J. R., & Smith, J. D. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4601 · Cited by 129
Youdim, M. B. H., Fridkin, M., & Zheng, H. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.023 · Cited by 128
Blokland, A., & JOLLES, J. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90497-h · Cited by 128
Zhang, X., Heng, X., Li, T., Li, L., Yang, D., Zhang, X., Du, Y., Doody, R. S., & Le, W. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101875 · Cited by 126
Wheel-running in a transgenic mouse model of Alzheimer's disease: Protection or symptom?
Richter, H., Ambrée, O., Lewejohann, L., Herring, A., Keyvani, K., Paulus, W., Palme, R., Touma, C., Schäbitz, W., & Sachser, N. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.005 · Cited by 122
A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease
Weyer, G., Babej-Dölle, R. M., Hadler, D., Hofmann, S., & Herrmann, W. M. (2008) · Neuropsychobiology · doi:10.1159/000119366 · Cited by 120
Prickaerts, J., Fahrig, T., & Blokland, A. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00158-2 · Cited by 120
Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease
Jiménez‐Jiménez, F. J., de Bustos, F., Molina, J. A., Benito‐León, J., Tallón-Barranco, A., Gasalla, T., Pareja, M. O., Guillamón, F., Rubio‐Terres, C., Arenas, J., et al. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291887 · Cited by 112
Bi, H., & Sze, C. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00087-4 · Cited by 111
Tzimopoulou, S., Cunningham, V. J., Nichols, T. E., Searle, G. E., Bird, N., Mistry, P. C., Dixon, I. J., Hallett, W. A., Whitcher, B. J., Brown, A. P., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100939 · Cited by 109
Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)
Hoyer, S., Lannert, H., Nöldner, M., & Chatterjee, S. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050232 · Cited by 109
Self-citationBraida, D., Paladini, E., Griffini, P., Lamperti, M., Maggi, A., & Sala, M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00072-6 · Cited by 108
New polyphenols active on β-amyloid aggregation
Rivière, C., Richard, T., Vitrac, X., Mérillon, J., Valls, J., & Monti, J. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.028 · Cited by 105
Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease
Medina, M., & Ávila, J. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793176581 · Cited by 103
Tota, S., Kamat, P. K., Awasthi, H., Singh, N., Raghubir, R., Nath, C., & Hanif, K. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.044 · Cited by 99
Li, L., Zhang, Z., Hölscher, C., Gao, C., Jiang, Y., & Liu, Y. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.005 · Cited by 98
Shonesy, B. C., Kariharan, T., Parameshwaran, K., Rahman, E. A., Karuppagounder, S. S., Huggins, K. W., Pinkert, C. A., Amin, R., Dhanasekaran, M., & Suppiramaniam, V. D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.002 · Cited by 98
Tota, S., Kamat, P. K., Shukla, R., & Nath, C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.041 · Cited by 97
Hellweg, R., Nitsch, R. M., Hock, C., Jaksch, M., & Hoyer, S. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310310 · Cited by 92
Self-citationSharma, B., Singh, N., & Singh, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081553 · Cited by 91
Sharma, M., & Gupta, Y. K. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00008-7 · Cited by 89
Kupershmidt, L., Amit, T., Bar‐Am, O., Youdim, M. B. H., & Weinreb, O. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4279 · Cited by 89
Study of neuroprotection of donepezil, a therapy for Alzheimer's disease
Akasofu, S., Kimura, M., Kosasa, T., Sawada, K., & OGURA, H. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.045 · Cited by 88
Awasthi, H., Tota, S., Hanif, K., Nath, C., & Shukla, R. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.007 · Cited by 86
Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy
Boimel, M., Grigoriadis, N., Lourbopoulos, A., Touloumi, O., Rosenmann, D., Abramsky, O., & Rosenmann, H. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31819ac3cb · Cited by 86
The role of iron as a mediator of oxidative stress in Alzheimer disease
Castellani, R. J., Moreira, P. I., Perry, G. L., & Zhu, X. (2012) · BioFactors · doi:10.1002/biof.1010 · Cited by 86
Kupershmidt, L., Weinreb, O., Amit, T., Mandel, S. A., Bar‐Am, O., & Youdim, M. B. H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.040 · Cited by 85
Weinstock, M., KIRSCHBAUM‐SLAGER, N., Lazarovici, P., Bejar, C., Youdim, M. B. H., & Shoham, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03622.x · Cited by 80
Cognitive evaluation of disease-modifying efficacy of Galantamine and Memantine in the APP23 model
Dam, D. V., & Deyn, P. P. D. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.06.005 · Cited by 78
Borroni, B., Grassi, M., Agosti, C., Costanzi, C., Archetti, S., Franzoni, S., Caltagirone, C., Luca, M. D., Caimi, L., & Padovani, A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.029 · Cited by 78
Isik, A. T., Celik, T., Ulusoy, G., Ongoru, O., Elibol, B., Doruk, H., Bozoglu, E., Kayir, H., Mas, M. R., & Akman, S. (2009) · AGE · doi:10.1007/s11357-008-9078-8 · Cited by 76
Saxena, G., Patro, I. K., & Nath, C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.039 · Cited by 74
Tramontina, A. C., Wartchow, K. M., Rodrigues, L., Biasibetti, R., Quincozes‐Santos, A., Bobermin, L. D., Tramontina, F. F., & Gonçalves, C. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0680-z · Cited by 72
Jee, Y., Ko, I., Sung, Y.-H., Lee, J. W., Kim, Y., Kim, S. E., Kim, B.-K., Seo, J.-H., Shin, M.-S., Lee, H., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.07.078 · Cited by 70
Hou, Y., Zhou, L., Yang, Q. D., Du, X., Li, M., Yuan, M., & Zhou, Z. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.030 · Cited by 66
Giorgino, F., Chen, J. H., & Smith, R. J. (1992) · Endocrinology · doi:10.1210/endo.130.3.1531627 · Cited by 66
Ponce-López, T., Liy-Salmerón, G., Hong, E., & Meneses, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.09.056 · Cited by 65
Gene expression profile in streptozotocin rat model for sporadic Alzheimer?s disease
Grünblatt, E., Hoyer, S., & Riederer, P. F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0030-x · Cited by 64
Self-citationRodrigues, L., Biasibetti, R., Swarowsky, A., Leite, M. C., Quincozes‐Santos, A., Quilfeldt, J. A., Achaval, M., & Gonçalves, C. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1034 · Cited by 62
Hoyer, S., & Lannert, H. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_25 · Cited by 60
Self-citationTota, S., Kamat, P. K., Saxena, G., Hanif, K., Najmi, A. K., & Nath, C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.07.047 · Cited by 60
Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats.
Blondel, O., & Portha, B. (1989) · PubMed · Cited by 56
Lannert, H., Wirtz, P., Schuhmann, V., & Galmbacher, R. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050111 · Cited by 55
Organoselenium improves memory decline in mice: Involvement of acetylcholinesterase activity
Pinton, S., da Rocha, J. T., Zeni, G. R., & Nogueira, C. W. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.057 · Cited by 54
Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats
Blokland, A., & JOLLES, J. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90284-4 · Cited by 54
Shingo, A. S., Kanabayashi, T., Murase, T., & Kito, S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.034 · Cited by 54
Hajjar, I. M., Keown, M., Lewis, P., & Almor, A. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507309803 · Cited by 54
Rodrigues, L., Dutra, M. F., Ilha, J., Biasibetti, R., Quincozes‐Santos, A., Leite, M. C., Marcuzzo, S., Achaval, M., & Gonçalves, C. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0501-9 · Cited by 51
Ishrat, T., Parveen, K., Hoda, M. N., Khan, M. B., Yousuf, S., Ansari, M. A., Saleem, S., & Islam, F. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c7125 · Cited by 51
Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer’s Disease
Gunnarsson, M. D., Kilander, L., Basun, H., & Lannfelt, L. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107099 · Cited by 51
Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia
Rinwa, P., Kaur, B., Jaggi, A. S., & Singh, N. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0511-z · Cited by 50
Dhull, D. K., Jindal, A., Dhull, R. K., Aggarwal, S., Bhateja, D., & Padi, S. S. V. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9583-6 · Cited by 50
Heo, J., Lee, S., Lee, S., Lee, K., Oh, J.-H., Jang, D. P., Chang, K.-T., & Cho, Z. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102079 · Cited by 49
Misra, S., Tiwari, V., Kuhad, A., & Chopra, K. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.026 · Cited by 48
Terwel, D., Prickaerts, J., Meng, F., & JOLLES, J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00475-4 · Cited by 43
Exploring mechanism of pioglitazone‐induced memory restorative effect in experimental dementia
Kaur, B., Singh, N., & Jaggi, A. S. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00708.x · Cited by 42
Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice
Kupershmidt, L., Amit, T., Bar‐Am, O., Youdim, M. B. H., & Weinreb, O. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.03.001 · Cited by 40
Sharma, B., Singh, N., Singh, M., & Jaggi, A. S. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.02.012 · Cited by 40
Prickaerts, J., Blokland, A., Honig, W. M. M., Meng, F., & Jolles, J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00006-c · Cited by 39
Sharma, V., Bala, A., Deshmukh, R. R., Bedi, K. L., & Sharma, P. L. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.01.004 · Cited by 38
Carvedilol Reestablishes Long-Term Potentiation in a Mouse Model of Alzheimer's Disease
Arrieta‐Cruz, I., Wang, J., Pavlides, C., & Pasinetti, G. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100225 · Cited by 37
Alzheimer Disease—No Target for Statin Treatment. A Mini Review
Hoyer, S., & Riederer, P. F. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9168-x · Cited by 34
Self-citationDalla, Y., Singh, N., Jaggi, A. S., & Singh, D. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70339-x · Cited by 34
Kumar, R., Jaggi, A. S., & Singh, N. (2010) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2010.14.5.345 · Cited by 30
Pinton, S., da Rocha, J. T., Gai, B. M., Prigol, M., Rosa, L. V., & Nogueira, C. W. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1741 · Cited by 30
Youdim, M. B. H. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70047-5 · Cited by 29
Potential of ezetimibe in memory deficits associated with dementia of Alzheimer′s type in mice
Singh, N., Dalla, Y., Jaggi, A. S., Singh, D., & Ghulati, P. (2009) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.59925 · Cited by 29
Prakash, A. K., & Kumar, A. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.12.0012 · Cited by 29
Löffler, T., Lee, S. K., Nöldner, M., Chatterjee, S. S., Hoyer, S., & Schliebs, R. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100020 · Cited by 27
Self-citationMuller, A. P., Zimmer, E. R., Kalinine, E., Haas, C. B., Oses, J. P., de Assis, A. M., Galina, A., Souza, D. O., & Portela, L. V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112066 · Cited by 24
Diwu, Y. (2011) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20110215 · Cited by 10
Experimental approach to Alzheimer's disease
Šalković‐Petrišić, M., Hoyer, S., & Riederer, P. F. (2013) · Cited by 1
Self-citation
Cited by
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Kerr, J. S., Adriaanse, B. A., Greig, N. H., Mattson, M. P., Cader, M. Z., Bohr, V. A., & Fang, E. F. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.01.002 · Cited by 870
Goyal, S. N., Reddy, N. M., Patil, K. R., Nakhate, K. T., Ojha, S., Patil, C. R., & Agrawal, Y. O. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.032 · Cited by 419
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
Yarza, R., Vela, S., Solas, M., & Ramirez, M. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00321 · Cited by 410
Grieb, P. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9132-3 · Cited by 361
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Bassil, F., Fernagut, P.-O., Bezard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 309
Metadata
- Authors
- Salkovic-Petrisic, M., Knezovic, A., Hoyer, S., & Riederer, P.
- Venue
- Journal of Neural Transmission
- Published
- 2012-08-12
- Volume
- 120
- Issue
- 1
- Pages
- 233-252
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W1978304543
- Cited by
- 272
- References
- 169
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.